3 years ago
VKTX
AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 3%
#153 out of 5555 analysts
Average Return
+21.17%
Win Rate
44%109 out of 248
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +741.69% | $39.82 | $335.16 | 2025-06-02 - 2026-06-01 | Buy |
Praxis Precision Medicines IncPRAX | +592.79% | $46.76 | $323.95 | 2025-07-08 - 2026-07-07 | Buy |
89bio IncETNB | +578.03% | $2.64 | $17.90 | 2022-05-13 - 2023-05-12 | Buy |
Terns Pharmaceuticals IncTERN | +550.49% | $8.14 | $52.95 | 2025-10-22 - 2026-05-04 | Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-30 - 2023-06-29 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
3 years ago
VKTX
3 years ago
VKTX
4 years ago
VKTX
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Retension Pharmaceuticals IncRTSN | 1 | Buy | $50.00 | +366.42% | Initiates Coverage On | 3 days ago |
Incyte CorpINCY | 12 | Buy | $144.00 | +22.02% | Upgrades | 7 days ago |
Amgen IncAMGN | 19 | Buy | $480.00 | +4.28% | Maintains | 14 days ago |
Sagimet Biosciences IncSGMT | 2 | Buy | $38.00 | +316.67% | Maintains | a month ago |
Revolution Medicines IncRVMD | 13 | Buy | $260.00 | +46.36% | Maintains | 2 months ago |
Faeth Therapeutics IncFTH | 1 | Buy | $60.00 | +201.20% | Initiates Coverage On | 3 months ago |
Q32 Bio IncQTTB | 3 | Buy | $40.00 | +351.98% | Maintains | 4 months ago |
Kyntra Bio IncKYNB | 1 | Buy | $35.00 | +856.28% | Initiates Coverage On | 4 months ago |
Eupraxia Pharmaceuticals IncEPRX | 1 | Buy | $17.00 | +157.58% | Initiates Coverage On | 4 months ago |
Definium Therapeutics IncDFTX | 2 | Buy | $60.00 | +97.63% | Maintains | 4 months ago |
Praxis Precision Medicines IncPRAX | 4 | Buy | $650.00 | +147.53% | Maintains | 5 months ago |
Adlai Nortye Group LtdANL | 1 | Buy | $32.00 | +230.58% | Initiates Coverage On | 5 months ago |
Passage Bio IncPASG | 2 | Buy | $15.00 | +333.53% | Maintains | 7 months ago |
Biogen IncBIIB | 22 | Buy | $275.00 | +12.74% | Maintains | 7 months ago |
Bicycle Therapeutics PLCBCYC | 5 | Buy | $36.00 | +934.48% | Maintains | 8 months ago |
Vertex Pharmaceuticals IncVRTX | 2 | Buy | $600.00 | +10.60% | Maintains | 8 months ago |
Bioage Labs IncBIOA | 1 | Buy | $60.00 | +983.03% | Initiates Coverage On | 8 months ago |
Acadia Pharmaceuticals IncACAD | 13 | Hold | $23.00 | +8.29% | Maintains | 9 months ago |
Coherus Oncology IncCHRS | 1 | Buy | $10.00 | +1,235.11% | Initiates Coverage On | 10 months ago |
Terns Pharmaceuticals IncTERN | 4 | Buy | $58.00 | +9.54% | Maintains | a year ago |
Madrigal Pharmaceuticals IncMDGL | 10 | Buy | $650.00 | +62.46% | Maintains | a year ago |
Ibio IncIBIO | 1 | Buy | $5.00 | N/A | Initiates Coverage On | a year ago |
Ionis Pharmaceuticals IncIONS | 4 | Buy | $90.00 | N/A | Maintains | a year ago |
Immuneering CorpIMRX | 3 | Buy | $30.00 | N/A | Maintains | a year ago |
Ataibeckley IncATAI | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Prothena Corp Public Ltd CoPRTA | 12 | Hold | N/A | N/A | Downgrades | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Buy | $65.00 | N/A | Initiates Coverage On | a year ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $1,950.00 | N/A | Maintains | a year ago |
Inovio Pharmaceuticals IncINO | 3 | Buy | $13.00 | N/A | Maintains | a year ago |
Nektar TherapeuticsNKTR | 6 | Buy | $90.00 | N/A | Upgrades | 2 years ago |
Denali Therapeutics IncDNLI | 4 | Buy | $42.00 | N/A | Maintains | 2 years ago |
Exelixis IncEXEL | 6 | Hold | $33.00 | N/A | Downgrades | 2 years ago |
Intellia Therapeutics IncNTLA | 9 | Buy | $40.00 | N/A | Maintains | 2 years ago |
Sage Therapeutics IncSAGE | 8 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Damora Therapeutics IncDMRA | 4 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Viking Therapeutics IncVKTX | 8 | Buy | $138.00 | N/A | Reiterates | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 6 | Buy | $6.00 | N/A | Upgrades | 2 years ago |
Gain Therapeutics IncGANX | 1 | Buy | $8.00 | N/A | Assumes | 2 years ago |
Neurocrine Biosciences IncNBIX | 12 | Buy | $219.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 6 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 5 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Sutro Biopharma IncSTRO | 5 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 6 | Buy | $95.00 | N/A | Maintains | 2 years ago |
Skye Bioscience IncSKYE | 1 | Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Cognition Therapeutics IncCGTX | 4 | Buy | $9.00 | N/A | Maintains | 3 years ago |
89bio IncETNB | 5 | Hold | N/A | N/A | Maintains | 3 years ago |
Biovie IncBIVI | 4 | Buy | $500.00 | N/A | Maintains | 3 years ago |
Enanta Pharmaceuticals IncENTA | 7 | Hold | $21.00 | N/A | Maintains | 3 years ago |
Immunogen IncIMGN | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Mirati Therapeutics IncMRTX | 7 | Buy | $62.00 | N/A | Maintains | 3 years ago |
Cymabay Therapeutics IncCBAY | 3 | Buy | $16.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $280.00 | N/A | Reiterates | 3 years ago |
Seagen IncSGEN | 8 | Buy | $229.00 | N/A | Maintains | 4 years ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | N/A | Downgrades | 5 years ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | 5 years ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 6 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 7 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 9 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $2,520.00 | N/A | Maintains | 9 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 9 years ago |
Therapeuticsmd IncTXMD | 2 | Buy | N/A | N/A | Upgrades | 9 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 9 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.